Goldman Sachs Starts Mineralys Therapeutics, Inc. (MLYS) at Buy, 'Upcoming Pivotal Results Could Surprise on the Upside'
Tweet Send to a Friend
(Updated - April 2, 2024 3:44 AM EDT)
Goldman Sachs analyst Richard Law initiates coverage on Mineralys Therapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Goldman Sachs analyst Richard Law initiates coverage on Mineralys Therapeutics, Inc ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
